1147 related articles for article (PubMed ID: 8666803)
1. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface.
Wolfram M; Fuchs M; Wiese M; Stierhof YD; Overath P
Eur J Immunol; 1996 Dec; 26(12):3153-62. PubMed ID: 8977317
[TBL] [Abstract][Full Text] [Related]
3. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
Kima PE; Soong L; Chicharro C; Ruddle NH; McMahon-Pratt D
Eur J Immunol; 1996 Dec; 26(12):3163-9. PubMed ID: 8977318
[TBL] [Abstract][Full Text] [Related]
4. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
6. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.
Courret N; Prina E; Mougneau E; Saraiva EM; Sacks DL; Glaichenhaus N; Antoine JC
Eur J Immunol; 1999 Mar; 29(3):762-73. PubMed ID: 10092078
[TBL] [Abstract][Full Text] [Related]
7. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.
Kima PE; Ruddle NH; McMahon-Pratt D
J Immunol; 1997 Aug; 159(4):1828-34. PubMed ID: 9257846
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC
J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites.
Wolfram M; Ilg T; Mottram JC; Overath P
Eur J Immunol; 1995 Apr; 25(4):1094-100. PubMed ID: 7737279
[TBL] [Abstract][Full Text] [Related]
10. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
11. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
12. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
13. Control of Leishmania major by a monoclonal alpha beta T cell repertoire.
Reiner SL; Fowell DJ; Moskowitz NH; Swier K; Brown DR; Brown CR; Turck CW; Scott PA; Killeen N; Locksley RM
J Immunol; 1998 Jan; 160(2):884-9. PubMed ID: 9551925
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
17. Induction of macrophage killing of Leishmania donovani by human CD4+ T cell clones.
Melby PC; Valencia-Pacheco G; Andrade-Narváez F
Arch Med Res; 1996; 27(4):473-9. PubMed ID: 8987180
[TBL] [Abstract][Full Text] [Related]
18. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
19. Antigen-reactive gamma delta T cells in human leishmaniasis.
Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
[TBL] [Abstract][Full Text] [Related]
20. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
